title: Plasma physostigmine concentrations after controlled-release oral administration.
authors.forename: L J
authors.initials: LJ
authors.lastname: Thal
authors.forename: B
authors.initials: B
authors.lastname: Lasker
authors.forename: N S
authors.initials: NS
authors.lastname: Sharpless
authors.forename: G
authors.initials: G
authors.lastname: Bobotas
authors.forename: J M
authors.initials: JM
authors.lastname: Schor
authors.forename: A
authors.initials: A
authors.lastname: Nigalye
mesh_terms: D000284:Administration, Oral; D000544:Alzheimer Disease / Q000188:drug therapy; D003692:Delayed-Action Preparations; D006801:Humans; D008297:Male; D010830:Physostigmine / Q000008:administration & dosage / Q000097:blood*
chemical_list: D003692:Delayed-Action Preparations; D010830:Physostigmine